Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study
阿托伐他汀与瑞舒伐他汀治疗可减少 2 型糖尿病患者的尿液足细胞、足细胞相关分子和近端小管功能障碍生物标志物：一项初步研究
期刊:Renal Failure
影响因子:3
doi:10.1080/0886022X.2016.1254657
Adrian Vlad, Mihaela Vlad, Ligia Petrica, Sorin Ursoniu, Florica Gadalean, Roxana Popescu, Daliborca Vlad, Victor Dumitrascu, Gheorghe Gluhovschi, Cristina Gluhovschi, Silvia Velciov, Flaviu Bob, Petru Matusz, Alina Secara, Anca Simulescu, Dragos Catalin Jianu
